Volume 9, Issue 3

Addressing Management Challenges in HIV with Comorbid Infections

In this issue:

People living with HIV (PLWH) face an increased risk of comorbid infections such as hepatitis B virus (HBV), hepatitis C virus (HCV), and tuberculosis (TB). Consequently, clinicians may be challenged in their ability to evaluate and implement optimal treatment regimens to manage PLWH with comorbid infections.

In this issue of eHIV Review, Sonya Krishnan, MD, MHS, Assistant Professor of Medicine at Johns Hopkins Medicine, and Zachary W. Lorenz, MD, Infectious Diseases Fellow at Johns Hopkins University School of Medicine, discuss ways to improve and optimize the management protocols for PLWH and comorbid infections according to current guidelines. Learners will expect to improve their awareness of the latest advancements in HCV, HBV, and TB treatments and how to incorporate these therapies appropriately in the overall management of HIV.

Learning objective:

Evaluate optimal regimens for patients living with HIV and other comorbid infections (eg, TB, hepatitis B).


Sonya Krishnan, MD, MHS
Sonya Krishnan, MD, MHS

Associate Professor, Infectious Diseases Fellowship Program
Assistant Professor of Medicine
Johns Hopkins Medicine
Baltimore, MD

Zachary W. Lorenz, MD
Zachary W. Lorenz, MD

Infectious Diseases Fellow
Johns Hopkins University School of Medicine
Baltimore, MD

Program Directors:

Justin Alves, RN, FNP-BC, ACRN, CARN, CNE

Nurse Educator
Boston Medical Center
Boston, MA

Matthew Spinelli, MD, MAS

Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California

Ethel D. Weld, MD, PhD

Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland

Length of activity:

1.0 hour Physicians
1.0 contact hour Nurses

Launch date: June 20, 2024
Expiration date: June 19, 2026